Breast Cancer

MRI successfully gauges treatment response

Published in Women's Health Weekly, July 10th, 2003

Magnetic resonance (MR) imaging can accurately monitor early response to chemotherapy in patients with breast cancer, according to a study appearing in the July 2003 issue of the journal Radiology.

Chemotherapy is designed to diminish tumor size and reduce the number of blood vessels feeding the tumor. The study, conducted at Harvard Medical School and Massachusetts General Hospital in Boston and Caritas St. Elizabeth's Medical Center in Brighton, Massachusetts, found that contrast-enhanced MR imaging is a reliable, non-invasive way to measure blood flow to the tumor, thus gauging the success of chemotherapy.

"The more vessels a tumor has, the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2003-07-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry